Changes in Risk Tolerance for Ovarian Cancer Prevention Strategies during the COVID-19 Pandemic: Results of a Discrete Choice Experiment
In this discrete choice experiment, women were much less likely to choose prevention scenarios that had higher ovarian cancer risk prior to the COVID-19 pandemic than after the pandemic.The attenuation of preferences may have persisted through 2022.COVID-19 may have altered the relative importance of factors that motivate women to undergo risk-reducing surgeries.
Authors
- Alexander Husband (ORCID: https://orcid.org/0009-0000-6033-529X)
- Yu-Ning Wong
- Brian Lee Egleston (ORCID: https://orcid.org/0000-0002-1633-799X)
- Lisa Bealin
- Jill E. Stopfer (ORCID: https://orcid.org/0000-0001-7724-3471)
- Kaitlyn Lew
- Pawel Przybysz
- Timothy Richard Rebbeck (ORCID: https://orcid.org/0000-0002-4799-1900)
- Olga Tchuvatkina
- Judy E. Garber
- Mary B. Daly
Institutions
- Fox Chase Cancer Center (US)
- Harvard University (US)
- Dana-Farber Cancer Institute (US)
- Temple University Health System (US)
- Philadelphia VA Medical Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Medical Decision Making
- Published
- 2024-12-25
- DOI
- https://doi.org/10.1177/0272989x241302829
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute